Julio Gutiérrez

3.6k total citations · 2 hit papers
82 papers, 2.8k citations indexed

About

Julio Gutiérrez is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Julio Gutiérrez has authored 82 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hepatology, 33 papers in Epidemiology and 25 papers in Molecular Biology. Recurrent topics in Julio Gutiérrez's work include Hepatitis C virus research (31 papers), Liver Disease Diagnosis and Treatment (25 papers) and Hepatitis B Virus Studies (15 papers). Julio Gutiérrez is often cited by papers focused on Hepatitis C virus research (31 papers), Liver Disease Diagnosis and Treatment (25 papers) and Hepatitis B Virus Studies (15 papers). Julio Gutiérrez collaborates with scholars based in United States, Spain and United Kingdom. Julio Gutiérrez's co-authors include Gabriel Márquez, Ángel Zaballos, Rosa Varona, Carlos Ardavı́n, Íñigo Goya, Andrea D. Branch, Leonor Kremer, Carlos Martı́nez-A, Margarita Salas and Laura Carramolino and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

Julio Gutiérrez

76 papers receiving 2.7k citations

Hit Papers

TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcohol... 2021 2026 2022 2024 2021 2024 50 100 150

Peers

Julio Gutiérrez
Julio Gutiérrez
Citations per year, relative to Julio Gutiérrez Julio Gutiérrez (= 1×) peers Franco M. Buonaguro

Countries citing papers authored by Julio Gutiérrez

Since Specialization
Citations

This map shows the geographic impact of Julio Gutiérrez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julio Gutiérrez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julio Gutiérrez more than expected).

Fields of papers citing papers by Julio Gutiérrez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julio Gutiérrez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julio Gutiérrez. The network helps show where Julio Gutiérrez may publish in the future.

Co-authorship network of co-authors of Julio Gutiérrez

This figure shows the co-authorship network connecting the top 25 collaborators of Julio Gutiérrez. A scholar is included among the top collaborators of Julio Gutiérrez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julio Gutiérrez. Julio Gutiérrez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fütterer, Agnes, Sara Rodríguez‐Acebes, Juan Méndez, Julio Gutiérrez, & Carlos Martı́nez-A. (2024). PARP1, DIDO3, and DHX9 Proteins Mutually Interact in Mouse Fibroblasts, with Effects on DNA Replication Dynamics, Senescence, and Oncogenic Transformation. Cells. 13(2). 159–159. 2 indexed citations
2.
Harrison, Stephen A., Sarah Browne, John J. Suschak, et al.. (2024). Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled study. Journal of Hepatology. 82(1). 7–17. 65 indexed citations breakdown →
3.
Gutiérrez, Julio, et al.. (2024). S4328 Hepatocellular Adenoma Presenting With Concomitant Rupture and Hepatocellular Carcinoma. The American Journal of Gastroenterology. 119(10S). S2780–S2780.
4.
Alukal, Joseph J., et al.. (2023). State of the Art. Clinics in Liver Disease. 27(4). 937–954. 6 indexed citations
5.
Gutiérrez, Julio, Karel H. M. van Wely, & Carlos Martı́nez-A. (2022). Hepatitis, testicular degeneration, and ataxia in DIDO3-deficient mice with altered mRNA processing. Cell & Bioscience. 12(1). 84–84. 2 indexed citations
6.
Fütterer, Agnes, et al.. (2021). Impaired stem cell differentiation and somatic cell reprogramming in DIDO3 mutants with altered RNA processing and increased R-loop levels. Cell Death and Disease. 12(7). 637–637. 8 indexed citations
7.
Lawitz, Eric, Fred Poordad, Julio Gutiérrez, et al.. (2020). Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus‐infected patients: Long‐term follow‐up results from the open‐label, Phase II IMPACT study. Health Science Reports. 3(2). e145–e145. 5 indexed citations
8.
Carrion, Andres F., Julio Gutiérrez, & Paul Martin. (2014). New antiviral agents for the treatment of hepatitis C: ABT-450. Expert Opinion on Pharmacotherapy. 15(5). 711–716. 21 indexed citations
9.
Gutiérrez, Julio. (2014). Vitamin D Metabolites Inhibit Hepatitis C Virus and Modulate Cellular Gene Expression. PubMed. 3(3). 23 indexed citations
10.
Chamorro, Sonia, María Vela, Ana Franco‐Villanueva, et al.. (2014). Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts. mAbs. 6(4). 1000–1012. 31 indexed citations
11.
Gutiérrez, Julio, Neil Parikh, & Andrea D. Branch. (2011). Classical and Emerging Roles of Vitamin D in Hepatitis C Virus Infection. Seminars in Liver Disease. 31(4). 387–398. 52 indexed citations
12.
Fishman, Sarah L., Julio Gutiérrez, Christina Wyatt, et al.. (2010). Short Communication: Inadequate Vitamin D Exacerbates Parathyroid Hormone Elevations in Tenofovir Users. AIDS Research and Human Retroviruses. 26(8). 855–859. 55 indexed citations
13.
Gutiérrez, Julio, Arielle Klepper, John J. Garber, et al.. (2010). Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid. Journal of Virological Methods. 171(1). 169–175. 2 indexed citations
14.
Chang, Theresa L., Arielle Klepper, Jian Ding, et al.. (2010). Human Peritoneal Macrophages From Ascitic Fluid Can be Infected by a Broad Range of HIV-1 Isolates. JAIDS Journal of Acquired Immune Deficiency Syndromes. 53(3). 292–302. 4 indexed citations
15.
Lawal, Adeyemi, Christopher F. Basler, Andrea D. Branch, et al.. (2004). Influenza Vaccination in Orthotopic Liver Transplant Recipients: Absence of Post Administration ALT Elevation. American Journal of Transplantation. 4(11). 1805–1809. 41 indexed citations
16.
Goya, Íñigo, Ricardo Villares, Ángel Zaballos, et al.. (2003). Absence of CCR8 Does Not Impair the Response to Ovalbumin-Induced Allergic Airway Disease. The Journal of Immunology. 170(4). 2138–2146. 69 indexed citations
17.
Kremer, Leonor, Laura Carramolino, Íñigo Goya, et al.. (2001). The Transient Expression of C-C Chemokine Receptor 8 in Thymus Identifies a Thymocyte Subset Committed to Become CD4+ Single-Positive T Cells. The Journal of Immunology. 166(1). 218–225. 32 indexed citations
18.
Varona, Rosa, Ricardo Villares, Laura Carramolino, et al.. (2001). CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses. Journal of Clinical Investigation. 107(6). R37–R45. 180 indexed citations
19.
Goya, Íñigo, Julio Gutiérrez, Rosa Varona, et al.. (1998). Identification of CCR8 as the Specific Receptor for the Human β-Chemokine I-309: Cloning and Molecular Characterization of Murine CCR8 as the Receptor for TCA-3. The Journal of Immunology. 160(4). 1975–1981. 71 indexed citations
20.
Varona, Rosa, Ángel Zaballos, Julio Gutiérrez, et al.. (1998). Molecular cloning, functional characterization and mRNA expression analysis of the murine chemokine receptor CCR6 and its specific ligand MIP‐3α1. FEBS Letters. 440(1-2). 188–194. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026